Evidence for a role of endogenous opiates in postprandial somatostatin release.
Previously, we have demonstrated the effects of exogenously administered opiates on somatostatin release in dogs and therefore the present study was designed to determine the effect of endogenous opiates via naloxone-induced opiate receptor blockade on somatostatin release. Additionally, plasma insulin and pancreatic polypeptide (PP) levels were determined in response to intragastrically instilled protein, carbohydrate and fat test meals in a group of eight conscious dogs. To all test meals either naloxone (4 mg) or saline was added. The rise of plasma somatostatin levels in response to liver extract, sucrose and fat was attenuated significantly by naloxone. Naloxone had no effect on the rise of postprandial plasma insulin and PP levels. The present data demonstrate that endogenous opiates have a stimulatory effect on postprandial somatostatin release in dogs which indicates a tight interaction that might be of relevance for nutrient homeostasis.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D004041:Dietary Fats / Q000494:pharmacology; D004285:Dogs; D004435:Eating; D004723:Endorphins / Q000502:physiology*; D007328:Insulin / Q000097:blood; D009270:Naloxone / Q000494:pharmacology*; D010191:Pancreatic Polypeptide / Q000097:blood; D013004:Somatostatin / Q000097:blood / Q000378:metabolism*
D001786:Blood Glucose; D004041:Dietary Fats; D004723:Endorphins; D007328:Insulin; D009270:Naloxone; D013004:Somatostatin; D010191:Pancreatic Polypeptide